COVID-19 vaccine to be available by end of October: Pfizer CEO


A US-based multinational pharmaceutical company Pfizer’s Chief Executive Officer Albert Bourla announced that their vaccine against COVID-19 would be ready by the end of October.   Addressing a virtual event organised by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), Bourla said that Pfizer is conducting clinical trials in the US and Europe for the BNT162 vaccine programme to prevent COVID-19 in collaboration with German mRNA company BioNTech.